ACHF, in partnership with Pfizer, developed a digital brochure to be shared with students to help educate them on the causes, symptoms, and spread of serogroup B meningococcal disease (MenB). The brochure also highlights prevention of MenB through vaccination and the rates of MenB compared to other serogroups. Available materials include a PDF version as well as images to be shared on a campus website or through social media accounts.
This brochure can be posted directly on your campus health center website as either an image or a PDF, or shared on social media platforms.
· A PDF for printing or posting as link on a website
· An image for web posting (a PNG for posting as an image on a website)
· Social media-optimized images (PNGs for sharing on social media sites)
Available as a free download.
1Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403.
2Centers for Disease Control and Prevention. Meningococcal disease. Centers for Disease Control and Prevention website. https://www.cdc.gov-
/meningococcal/about/symptoms.html. Updated June 7, 2017.
3Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications
for prevention of meningococcal disease. Clin Infect Dis. 2010;50(2):184-191.
4Bettinger JA, Scheifele DW, Le Saux N, et al. The disease burden of invasive meningococcal serogroup B disease in Canada. Pediatr Infect Dis J.
5Borg J, Christie D, Coen PG, et al. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics.
6Centers for Disease Control and Prevention. Meningococcal surveillance. Centers for Disease Control and Prevention website.
7Meyer S. Epidemiology of meningococcal disease among college students – United States, 2014-2016. ACIP. February 2018.
8Christensen H, May M, Bowen L, et al. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis.
9World Health Organization. http://www.who.int/mediacentre/factsheets/fs141/en/. Reviewed January 2018.
10Tully J, Viner RM, Coen PG, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ.
11Dwillow R and Fanella S. Invasive meningococcal disease in the 21st century—an update for the clinician. Curr Neurol Neurosci Rep.
12MacNeil JR, Rubin L, Folaranmi T, et al. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the
Advisory Committee on Immunization Practices, 2015. MMWR. 2015;64(41):1171-1176.